Stroke - Acute interventions

Journal of Neural Transmission, Supplement

Volumn , Issue 63, 2002, Pages 37-57

  Heiss, W D ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANCROD; ANTICOAGULANT AGENT; GLYCEROL; HEPARIN; HETASTARCH; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; PLACEBO; PROUROKINASE; THROMBIN INHIBITOR; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HYPERTONIC SOLUTION;

BRAIN ANGIOGRAPHY; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DECOMPRESSION SURGERY; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; FIBRINOLYTIC THERAPY; HEMODILUTION; HUMAN; HYPOTHERMIA; MORTALITY; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECANALIZATION; REHABILITATION CENTER; REVIEW; SECONDARY PREVENTION; STROKE; BRAIN INFARCTION; CRYOANESTHESIA; REPERFUSION;

ANCROD; ANTICOAGULANTS; CEREBRAL ANGIOGRAPHY; CEREBRAL INFARCTION; DECOMPRESSION, SURGICAL; FIBRINOLYTIC AGENTS; HEMODILUTION; HUMANS; HYPERTONIC SOLUTIONS; HYPOTHERMIA, INDUCED; PLATELET AGGREGATION INHIBITORS; REPERFUSION; THROMBOLYTIC THERAPY;

EID: 0038621299     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6137-1_3     Document Type: Review

References (92)

1. Adams HPJr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W (1996) Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Ciculation 94: 1167-1174
2. Albers GW (1999) Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke 30: 2230-2237
3. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283: 1145-1150
4. Asplund K (1991) Hemodilution in acute stroke. Cerebrovasc Dis [Suppl]: 129-138
5. Astrup J, Siesjö BK, Symon L (1981) Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12: 723-725
6. Barinaga M (1998) Stroke-damaged neurons may commit cellular suicide. Science 281: 1302-1303
7. 15O positron emission tomography. Stroke 12: 454-459
8. Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19: 819-834
9. Bell WR, Pitney WR, Goodwin JF (1968) Therapeutic defibrination in the treatment of thrombotic disease. Lancet i: 490-493
10. Bereczki D, Lui M, do Prado GF, Fekete I (2000) A systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 31: 2722
11. Busto R, Dietrich WD, Globus MY, Ginsberg MD (1989) Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci Lett 101: 299-304
12. Chapman KM, Woolfenden AR, Graeb D, Johnston DC, Beckman J, Schulzer M, Teal PA (2000) Intravenous tissue plasminogen activator for acute ischemic stroke: a Canadian hospital's experience. Stroke 31: 2920-2924
13. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC (1998) Intravenous tissue plasminogen activator for acute ischemic stroke. Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29: 18-22
14. Davenport J, Hanson SK, Altafullah IM, Anderson DC, Brauer DJ, Brown RD, Ramirez-Lassepas M (2000) tPA: A rural network experience. Stroke 31: 1457
15. De Keyser J, Sulter G, Luiten PG (1999) Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? TINS-Trends Neurosci 22: 535-540
16. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78-86
17. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. TINS-Trends Neurosci 22: 391-397
18. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L (1989) Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 91: 311-322
19. Fisher M, Albers GW (1999) Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology 52: 1750-1756
20. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACTII study: a randomized controlled trial. JAMA-J Am Med Assoc 282: 2003-2011
21. Gottstein U (1984) Hemodilution: therapy in acute ischemic stroke. In: Bes A, Braquet P, Paoletti R, Siesjö BK (eds) Cerebral ischemia. Elsevier Science Publishers B.V., Amsterdam, pp 311-324
22. Grond M, Stenzel C, Schmülling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss W-D (1998) Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 29: 1544-1549
23. Grotta J (1994) The current status of neuronal protective therapy: why have all neuronal protective drugs worked in animals but none so far in stroke patients? Cerebrovasc Dis 4: 115-120
24. Grotta JC, Alexandrov AV (1998) tPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke 29: 429-432
25. Gubitz G, Counsell C, Sandercock P, Signorini D (2001a) Anticoagulants for acute ischaemic stroke (Cochrane Review). The Cochrane Library 3
26. Gubitz G, Sandercock P, Counsell C (2001b) Antiplatelet therapy for acute ischaemic stroke (Cochrane Review). The Cochrane Library 3
27. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA-J Am Med Assoc 274: 1017-1025
28. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R (1996) "Malignant" middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53: 309-315
29. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 352: 1245-1251
30. Hacke W, Brott T, Caplan L, Meier D, Fieschi C, von Kummer R, Donnan G, Heiss W-D, Wahlgren NG, Spranger M, Boysen G, Marler JR (1999) Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 53: S3-14
31. Hakim AM (1989) Hemodynamic and metabolic studies in stroke. Semin Neurol 9: 286-292
32. Hakim AM, Pokrupa RP, Villanueva J, Diksic M, Evans AC, Thompson CJ, Meyer E, Yamamoto YL, Feindel WH (1987) The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts. Ann Neurol 21: 279-289
33. Heiss W-D (2000) Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 20: 1276-1293
34. Heiss W-D, Graf R (1994) The ischemie penumbra. Curr Opin Neurol 7: 11-19
35. Heiss W-D, Prosenz P, Tschabitscher H, Lasek C, Herles HJ (1972) Effect of low molecular dextran on total cerebral blood flow and on regional flow within ischemic brain lesions. Eur Neurol 8: 129-133
36. Heiss W-D, Grond M, Thiel A, von Stockhausen HM, Rudolf J, Ghaemi M, Löttgen J, Stenzel C, Pawlik G (1998) Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 18: 1298-1307
37. Heiss W-D, Thiel A, Grond M, Graf R (1999) Which targets are relevant for therapy of acute ischemic stroke? Stroke 30: 1486-1489
38. 2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 31: 366-369
39. Heiss W-D, Graf R, Wienhard K (2001a) Relevance of experimental ischemia in cats for stroke management: a comparative reevaluation. Cerebrovasc Dis 11: 73-81
40. Heiss W-D, Kracht LW, Thiel A, Grond M, Pawlik G (2001b) Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 124: 20-29
41. Hickenbottom SL, Grotta J (1998) Neuroprotective therapy. Semin Neurol 18: 485-492
42. Hossmann K-A (1994) Viability thresholds and the penumbra of focal ischemia. Ann Neurol 36: 557-565
43. Hossmann V, Heiss W-D, Bewermeyer H, Wiedemann G (1983) Controlled trial of ancrod in ischemic stroke. Arch Neurol 40: 803-808
44. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL (1999) Stroke unit treatment. 10-Year follow-up. Stroke 30: 1524-1527
45. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K (1999) Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 353: 2036-2037
46. Jorgensen HS, Kammersgaard LP, Nakayama H, Raaschou HO, Larsen K, Hubbe P, Olsen TS (1999) Treatment and rehabilitation on a stroke unit improves 5-year survival. A community-based study. Stroke 30: 930-933
47. Kalra L, Evans A, Perez I, Knapp M, Donaldson N, Swift CG (2000) Alternative strategies for stroke care: a prospective randomised controlled trial. Lancet 356: 894-899
48. Karibe H, Chen J, Zarow GJ, Graham SH, Weinstein PR (1994) Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats. J Neurosurg 80: 112-119
49. Kaste M (2001) Thrombolysis in ischaemic stroke - present and future: role of combined therapy. Cerebrovasc Dis 11 [Suppl 1]: 55-59
50. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA (2000) Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283: 1151-1158
51. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR (2000) Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 47: 462-469
52. Klotz E, König M (1999) Perfusion measurements of the brain: using dynamic CT for the quantitative assessment of cerebral ischemia in acute stroke. Eur J Radiol 30: 170-184
53. Koroshetz WJ, Gonzales RG (1999) Imaging stroke in progress: magnetic resonance advances but computed tomography is poised for counterattack. Ann Neurol 46: 556-558
54. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T (1999) Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 340: 1781-1787
55. Lee JM, Zipfel GJ, Choi DW (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399: A7-A14
56. Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo J-M, Whitehead J (2000) Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet 355: 1949-1954
57. Liebeskind DS, Kasner SE (2001) Neuroprotection for ischaemic stroke: an unattainable goal? CNS Drugs 15: 165-174
58. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME (1999) Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 52: 1792-1798
59. Mathew NT, Meyer JS, Rivera VM, Charney JZ, Hartmann A (1972) Double-blind evaluation of glycerol treatment in acute cerebral infarction. Lancet ii: 1327-1329
60. Olinger CP, Brott TG, Barsan WG, Hedges JR, Glas-Greenwalt P, Pollak VE, Spilker J, Eberle R (1988) Use of ancrod in acute or progressing ischemic cerebral infarction. Ann Emerg Med 17: 1208-1209
61. Orgogozo JM, Verstraete M, Kay R, Hennerici M, Lenzi GL (2000) Outcomes of ancrod in acute ischemic stroke. Independent Data and Safety Monitoring Board for ESTAT. Steering Committee for ESTAT. European Stroke Treatment with Ancrod Trial. JAMA 284: 1926-1927
62. Plum F (2001) Neuroprotection in acute ischemic stroke. JAMA 285: 1760-1761
63. Pollak VE, Glas-Greenwalt P, Olinger CP, Wadhwa NK, Myre SA (1990) Ancrod causes rapid thrombolysis in patients with acute stroke. Am J Med Sci 299: 319-325
64. Restrepo L, Silverman IE (2001) Osmotherapy: a call to arms. Stroke 32: 811-812
65. Righetti E, Celani MG, Cantisani T, Sterzi R, Boysen G, Ricci S (2000) Glycerol for acute stroke (Cochrane Review). The Cochrane Library 3
66. Rubin G, Firlik AD, Pindzola RR, Levy EI, Yonas H (1999) The effect of reperfusion therapy on cerebral blood flow in acute stroke. J Stroke Cerebrovasc Dis 8: 1-9
67. Rudolf J, et al (2002) Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke - a randomized, placebo-controlled phase II safety study. Cerebrovasc Dis 14: 33-41
68. Ryu YH, Chung TS, Yoon PH, Kim DI, Lee JD, Lee BI, Suh JH (1999) Evaluation of reperfusion and recovery of brain function before and after intracarotid arterial urokinase therapy in acute cerebral infarction with brain SPECT. Clin Nucl Med 24: 566-571
69. Sacco RL, DeRosa JT, Haley EC, Jr, Levin B, Ordronneau P, Phillips SJ, Rundek T, Snipes RG, Thompson JL (2001) Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 285: 1719-1728
70. Sasaki O, Takeuchi S, Koizumi T, Koike T, Tanaka R (1996) Complete recanalization via fibrinolytic therapy can reduce the number of ischemic territories that progress to infarction. Am J Neuroradiol 17: 1661-1668
71. Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, Haley EC (1999) Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. Stroke 30: 293-298
72. Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W (2000) Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 31: 1318-1328
73. Schmülling S, Grond M, Rudolf J, Heiss W-D (2000) One-year follow-up in acute stroke patients treated with rtPA in clinical routine. Stroke 31: 1552-1554
74. Schneweis S, Grond M, Staub F, Brinker G, Neveling M, Dohmen C, Graf R, Heiss W-D (2001) Predictive value of neurochemical monitoring in large middle cerebral artery infarction. Stroke 32: 1863-1867
75. Schulz JB, Weller M, Moskowitz MA (1999) Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 45: 421-429
76. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W (1998) Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 29: 2461-2466
77. Segal AZ, Lev MH, Schwamm HL, Jeffery F, Jonathan R, Putman CM, Budzik RF, Hunter GJ, Rordorf G, Buonanno F, Koroshetz W, Gonzalez G (1999) CT-perfusion imaging in acute stroke with MCA stem occlusion: prediciting outcome after intraarterial (IA) thrombolysis. Stroke 30: 248
78. Sherman DG, Atkinson RP, Chippendale T, Levin KA, Ng K, Futrell N, Hsu CY, Levy DE, for the STAT Participants (2000) Intravenous ancrod for treatment of acute ischemic stroke. The STAT study: a randomized controlled trial. JAMA-J Am Med Assoc 283: 2395-2403
79. Steiner T, Ringleb P, Hacke W (2001) Treatment options for large hemispheric stroke. Neurology 57 [Suppl 2]: S61-S68
80. Stroke Unit Trialists' Collaboration (2001) Organised inpatient (stroke unit) care for stroke (Cochrane Review). The Cochrane Library 3
81. Tanne D, Demchuk AM, Kasner SE, Grond M, Hanson SK, Hamilton S, Buchan AM, Wang DZ, Wechsler LR, Zweifler RM, Levine SR (2000) A large multinational investigation to predict t-PA related symptomatic ICH in patients with acute ischemic stroke. Stroke 30: 248
82. The Ancrod Stroke Study Investigators (1994) Ancrod for the treatment of acute ischemic brain infarction. Stroke 25: 1755-1759
83. The European Ad Hoc Consensus Group (1996) European strategies for early internention in stroke. Cerebrovasc Dis 6: 315-324
84. The NINDS rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587
85. Trouillas P, Nighoghossian N, Derex L, Adeleine P, Honnorat J, Neuschwander P, Riche G, Getenet JC, Li W, Froment JC, Turjman F, Malicier D, Fournier G, Gabry AL, Ledoux X, Berthezene Y, Ffrench P, Dechavanne M (1998) Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke 29: 2529-2540
86. Ueda T, Sakaki S, Yuh WTC, Nochide I, Ohta S (1999) Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 19: 99-108
87. von Kummer R, Meyding-Lamade U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K (1994) Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 15: 9-15
88. Wahlgren NG, Macmahon DG, De Keyser J, Indredavik B, Ryman T (1994) Intravenous nimodipine West-European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 4: 204-210
89. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC (2000) Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke 31: 77-81
90. Wardlaw JM, Warlow CP, Counsell C (1997) Systematic review of evidence on thrombolytic therapy for acute ischemic stroke. Lancet 350: 607-614
91. Wardlaw JM, Del Zoppo G, Yamaguchi T (2000) Thrombolysis versus control in acute ischemic stroke (Cochrane Review). Cochrane Library 3
92. Weir CJ, Murray GD, Dyker AG, Lees KR (1997) Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 314: 1303-1306